|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




* Division of Geographic Medicine, Case Western Reserve University and
Veterans Affairs Medical Center, Cleveland, OH 44106;
Papua New Guinea Institute of Medical Research, Madang, Papua New Guinea; and
University of Notre Dame, South Bend, IN 46556
The Plasmodium vivax merozoite Duffy binding protein
(DBP) contains a cysteine-rich region II (DBPII) that binds to the
Duffy Ag receptor for chemokines on erythrocytes, which is essential
for parasite invasion. Cellular immune responses to DBPII have not been
reported in P. vivax endemic populations,
although they may contribute to partial acquired immunity. To examine
host cellular immunity to DBPII and identify major T cell epitopes,
PBMCs from 107 individuals (268 years old) were examined for cytokine
production by ELISPOT and/or ELISA to rDBP and overlapping peptides
(displaced by 2 aa spanning a 170-aa region of DBPII corresponding to
the critical binding motif to the Duffy Ag receptor for chemokines). In
P. vivax-exposed subjects, 60 and 71% generated
significant rDBP-induced IFN-
and IL-10 production, respectively,
11% stimulated IL-2, and IL-5 and IL-13 were not detected. Children
<5 years of age had reduced levels and frequency of rDBP-induced IL-10
and IFN-
production compared with partially immune older children
and adults (p < 0.01). Five major T cell epitopes
were identified. Three of these T cell epitopes contained polymorphic
residues present in the population. Peptides synthesized corresponding
to these variants induced IFN-
and IL-10 production to one variant
and little response to the other variant in the same individual. These
results demonstrate age-dependent and variant-specific cellular immune
responses to DBPII and implicate this molecule in partial acquired
immunity to P. vivax in endemic
populations.
This article has been cited by other articles:
![]() |
M. AREVALO-HERRERA, A. CASTELLANOS, S. S. YAZDANI, A. R. SHAKRI, C. E. CHITNIS, R. DOMINIK, and S. HERRERA IMMUNOGENICITY AND PROTECTIVE EFFICACY OF RECOMBINANT VACCINE BASED ON THE RECEPTOR-BINDING DOMAIN OF THE PLASMODIUM VIVAX DUFFY BINDING PROTEIN IN AOTUS MONKEYS Am J Trop Med Hyg, November 1, 2005; 73(5_suppl): 25 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xainli, J. L. Cole-Tobian, M. Baisor, W. Kastens, M. Bockarie, S. S. Yazdani, C. E. Chitnis, J. H. Adams, and C. L. King Epitope-Specific Humoral Immunity to Plasmodium vivax Duffy Binding Protein Infect. Immun., May 1, 2003; 71(5): 2508 - 2515. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |